Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Related Quality of Life in LCIG Patients and LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany and Switzerland - BALANCE

NCT02381444 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02381444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02381444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Related Quality of Life in LCIG Patients and LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany and Switzerland - BALANCE
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
April 17, 2015
Completion date
January 7, 2020
Enrollment
136 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)